FeedBagel

All Topics

Art

FTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Deal

[email protected]

16d ago

Source

bulkorder.ftc.govFTC Takes Action to Protect Americans from Higher Drug Costs in Aurobindo, Lannett Dealftc.gov

Snippet from the RSS feed

Proposed FTC order requires divestiture of four drug products to resolve anticompetitive concerns The Federal Trade Commission took action to protect American patients from higher drug costs by requiring Aurobindo Pharma Limited to divest four different generic drug products to complete its $250 million acquisition of Lannett Company Inc. View Press Release

You might also wanna read

White House Launches TrumpRx Direct-to-Consumer Drug Pricing Website

The White House has launched TrumpRx, a direct-to-consumer drug pricing website that allows patients to purchase certain medications at disc

cnbc.com·4mo ago

FDA Drug Regulator Accused of Targeting Former Business Associate's Pharmaceutical Company

The article discusses a scandal at the FDA involving a top drug regulator who allegedly used his position to target a former business associ

arstechnica.com·8mo ago

Senators Investigate Pharmaceutical Companies' Direct-to-Consumer Telehealth Platforms for Steering Patients to High-Cost Drugs

U.S. senators are investigating direct-to-consumer (DTC) telehealth platforms operated by pharmaceutical companies like Eli Lilly and Pfizer

arstechnica.com·5mo ago

U.S. launches tariff probe into Germany's pharmaceutical pricing policies

The U.S. has launched a tariff investigation into Germany's pharmaceutical pricing policies, accusing the country of "persistent underpaymen

cnb.cx·15d ago

Alibaba to pay $600 million to settle U.S. lawsuit over illegal drug sales on its platforms

Alibaba has agreed to pay $600 million to settle a lawsuit with the U.S. federal government over allegations that the company facilitated th

fox5dc.com·12h ago

Starmer's US pharma deal criticized as costly threat to NHS and public health

Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law facilitating a US medicine import deal

theguardian.com·2d ago

Comments

No comments yet. Be the first.